Form 4: eHealth Director Cesar M. Soriano Receives Annual Restricted Stock Units

Cesar M. Soriano, a director at eHealth, Inc., was granted 31,760 restricted stock units (RSUs) on June 11, 2024, as part of an annual award for non-employee directors.

Summary

• On June 11, 2024, Cesar M. Soriano, a director of eHealth, Inc., received an annual award of 31,760 restricted stock units (RSUs).
• Each RSU represents the right to receive one share of eHealth's common stock upon vesting.
• The RSUs vest in four equal quarterly installments starting from June 11, 2024, contingent upon continued service.
• Unvested RSUs will fully vest prior to the next annual stockholder meeting or upon a change in control, subject to continued service.

Sentiment

Score: 7

Explanation: The document reflects a standard equity grant to a director, which is generally viewed as a positive sign of alignment with shareholder interests. The sentiment is neutral to slightly positive.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• Vesting is tied to continued service, incentivizing ongoing commitment.

Risks

• The value of the RSUs is dependent on the future performance of eHealth's stock.
• The director must remain in service to fully vest the RSUs.

Future Outlook

The director's compensation is tied to the company's stock performance, incentivizing efforts to increase shareholder value.

Industry Context

Equity compensation is a common practice for directors of publicly traded companies to align their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• The size of the RSU grant is likely determined by factors such as company size, performance, and industry benchmarks.
• Comparing eHealth's director compensation to that of similar companies in the health insurance or technology sectors would provide further context.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with those of shareholders.
• Employees: The grant is unlikely to have a direct impact on employees.
• Customers: The grant is unlikely to have a direct impact on customers.

Key Dates